BIDMC informatrician receives Morris F.

Safran on his accomplishments in enhancing patient treatment at Beth Israel Deaconess INFIRMARY and Harvard's teaching hospitals and thank him for the clinical informatics leadership part he has played both throughout his profession and recently through the creation of the CI subspecialty of medication.’ ‘Dr. Safran has already established a profound effect on BIDMC and myself,’ added John Halamka, MD, BIDMC's Chief Info Officer. ‘I started my profession in his laboratory and 1st prototyped our BIDMC web-centered systems under his mentorship.’ Safran may be the previous President and Chairman of American Medical Informatics Association and once was Vice President of the International Medical Informatics Association.Amarin reports top-line outcomes from AMR101 Phase 3 trial for treatment of high triglycerides Amarin Company plc , a clinical-stage biopharmaceutical firm with a focus on cardiovascular disease, today reported positive, significant top-line outcomes from the MARINE study statistically, its first Phase 3 clinical trial of lead drug applicant AMR101. The study’s principal endpoint, the % switch in triglyceride levels from baseline to week 12, was fulfilled for both the 4 gram and 2 gram dose organizations. The MARINE research was required to fulfill a stringent level of statistical need for 1 percent , while agreed in the Company’s SPA with the FDA.

Other entries from category "slimming":

Random entries